Recruitment of participants has begun at our investigator-initiated trial at Portland Psychotherapy in Portland, Oregon. Dr. Jason Luoma and a team of researchers are conducting this study to assess the safety and effectiveness of MDMA-assisted therapy in treating individuals with moderate-to-severe social anxiety disorder (SAD). The team at Portland Psychotherapy plans to treat up to 20 participants. Visit the recruitment website to apply to participate. Enrollment continues for other study sites conducting Investigator-Initiated Trials. The MAPS Public Benefit Corporation (MAPS PBC) Investigator-Initiated Trial (IIT) program is designed to create an ever-growing network of qualified clinicians whose passion and innovative questioning help to inspire new possibilities within the path to expanding patient access and the conditions that MDMA-assisted therapy may be possible in treating.
